{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:50:12Z","timestamp":1773827412397,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.neuint.2020.104752","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T11:32:44Z","timestamp":1589974364000},"page":"104752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB1 receptors in rats"],"prefix":"10.1016","volume":"138","author":[{"given":"Ferenc","family":"Z\u00e1dor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Nagy-Gr\u00f3cz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"Dvor\u00e1csk\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Boh\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edina Katalin","family":"Cseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9nes","family":"Z\u00e1dori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"P\u00e1rdutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edina","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"T\u00f6mb\u00f6ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Borsodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Benyhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2020.104752_bib1","doi-asserted-by":"crossref","first-page":"109883","DOI":"10.1016\/j.pnpbp.2020.109883","article-title":"Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats","volume":"100","author":"Beggiato","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2020.104752_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2014.02.019","article-title":"Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex","volume":"82","author":"Beggiato","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2020.104752_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<249::AID-JNR7>3.0.CO;2-F","article-title":"Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain","volume":"48","author":"Benyhe","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2020.104752_bib4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1046\/j.1460-9568.2003.02951.x","article-title":"Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice","volume":"18","author":"Berrendero","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2020.104752_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(88)90814-X","article-title":"Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors","volume":"151","author":"Birch","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib6","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/npp.2013.153","article-title":"Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala","volume":"38","author":"Blasio","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2020.104752_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2017.04.023","article-title":"Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex","volume":"121","author":"Bortz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2020.104752_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2010.02.041","article-title":"Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus","volume":"210","author":"Carrillo-Mora","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2020.104752_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1471-4159.2010.07159.x","article-title":"Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis","volume":"118","author":"Chen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2020.104752_bib10","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjp.0706756","article-title":"Opioid and cannabinoid receptors: friends with benefits or just close friends?","volume":"148","author":"Christie","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib12","series-title":"Advances in Neurobiology","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-319-28383-8_10","article-title":"Cannabinoids: glutamatergic transmission and kynurenines","author":"Col\u00edn-Gonz\u00e1lez","year":"2016"},{"key":"10.1016\/j.neuint.2020.104752_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresrev.2005.10.004","article-title":"Cannabinoids, opioids and eating behavior: the molecular face of hedonism?","volume":"51","author":"Cota","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuint.2020.104752_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ab.2019.03.005","article-title":"HPLC method for the assessment of tryptophan metabolism utilizing separate internal standard for each detector","volume":"574","author":"Cseh","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2020.104752_bib15","series-title":"Assay Guidance Manual","article-title":"GTP\u03b3S binding assays","author":"DeLapp","year":"2004"},{"key":"10.1016\/j.neuint.2020.104752_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2020.104752_bib17","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3390\/ph3103101","article-title":"Endocannabinoids and schizophrenia","volume":"3","author":"Desfoss\u00e9s","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuint.2020.104752_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejmech.2019.05.037","article-title":"Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors","volume":"178","author":"Dvor\u00e1csk\u00f3","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuint.2020.104752_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2020.104752_bib20","first-page":"263","article-title":"Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results","volume":"8","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuint.2020.104752_bib21","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuint.2020.104752_bib22","article-title":"Receptor binding techniques","author":"Frey","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuint.2020.104752_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2020.104752_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2011.05.010","article-title":"Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa","volume":"70","author":"G\u00e9rard","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuint.2020.104752_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(90)90522-8","article-title":"The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia","volume":"176","author":"Gill","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.107.127266","article-title":"Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons","volume":"324","author":"Guo","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2020.104752_bib27","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2020.104752_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2020.104752_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.07.009","article-title":"The endocannabinoid system in mental disorders: evidence from human brain studies","volume":"157","author":"Ibarra-Lecue","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib30","doi-asserted-by":"crossref","first-page":"102mr2","DOI":"10.1126\/scitranslmed.3002804","article-title":"Translating glutamate: from pathophysiology to treatment","volume":"3","author":"Javitt","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2020.104752_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","article-title":"\u03949-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro","volume":"207","author":"Jenny","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuint.2020.104752_bib32","doi-asserted-by":"crossref","DOI":"10.1096\/fj.00-0438rev","article-title":"Inverse, protean, and ligand-selective agonism: matters of receptor conformation","volume":"15","author":"Kenakin","year":"2001","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2020.104752_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neures.2008.04.009","article-title":"The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid","volume":"61","author":"Knyihar-Csillik","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuint.2020.104752_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","article-title":"Structure of a signaling cannabinoid receptor 1-G protein complex","volume":"176","author":"Krishna Kumar","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2020.104752_bib35","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/jm4005219","article-title":"Bivalent ligands that target \u00ec opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance","volume":"56","author":"Le Naour","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2020.104752_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejcb.2008.03.003","article-title":"Kynurenic acid attenuates MPP(+)-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway","volume":"87","author":"Lee","year":"2008","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.neuint.2020.104752_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2020.104752_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"M\u00e1ndi","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2020.104752_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2020.104752_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2020.104752_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2011.02.002","article-title":"Orthologue selectivity and ligand bias: translating the pharmacology of GPR35","volume":"32","author":"Milligan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2020.104752_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/14756366.2016.1260565","article-title":"Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors","volume":"32","author":"Mollica","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuint.2020.104752_bib44","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3390\/ijms18081617","article-title":"Interactions between the kynurenine and the endocannabinoid system with special emphasis on migraine","volume":"18","author":"Nagy-Gr\u00f3cz","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2020.104752_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psyneuen.2014.10.012","article-title":"Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder","volume":"51","author":"Neumeister","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuint.2020.104752_bib46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00702-005-0343-z","article-title":"Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons","volume":"113","author":"Nilsson","year":"2006","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2020.104752_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2007.10.197","article-title":"GPR35 is a functional receptor in rat dorsal root ganglion neurons","volume":"365","author":"Ohshiro","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2020.104752_bib48","first-page":"981","article-title":"Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability","volume":"7","author":"Ol\u00e1h","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuint.2020.104752_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2020.104752_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuint.2020.104752_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00702-011-0665-y","article-title":"Kynurenines and headache","volume":"119","author":"P\u00e1rdutz","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2020.104752_bib52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0014-4886(85)90072-X","article-title":"Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo","volume":"88","author":"Perkins","year":"1985","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2020.104752_bib53","first-page":"S163","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2020.104752_bib55","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2014"},{"key":"10.1016\/j.neuint.2020.104752_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"Rodr\u00edguez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuint.2020.104752_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2017.02.053","article-title":"Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum","volume":"376","author":"Samavati","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2020.104752_bib58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0306-4522(98)00073-6","article-title":"Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro","volume":"86","author":"Scharfman","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2020.104752_bib59","article-title":"Astrocytic mechanisms involving kynurenic acid control d9-tetrahydrocannabinol-induced increases in glutamate release in brain reward-processing areas","volume":"1\u201313","author":"Secci","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2020.104752_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/mol.51.1.87","article-title":"mu-Opioid receptor-stimulated guanosine-5\u2019-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy","volume":"51","author":"Selley","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ntt.2010.10.002","article-title":"Protective effect of l-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy","volume":"33","author":"Silva-Adaya","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuint.2020.104752_bib63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Review: glutamate and dopamine dysregulation in schizophrenia \u2014 a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib64","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1476-5381.2010.00963.x","article-title":"Use of the GTP\u03b3S ([35S]GTP\u03b3S and Eu-GTP\u03b3S) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors","volume":"161","author":"Strange","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib65","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2174\/1568026611209061797","article-title":"Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction","volume":"12","author":"Szalardy","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuint.2020.104752_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2016.09.020","article-title":"Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia","volume":"633","author":"Sz\u0171cs","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2020.104752_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/biom10020284","article-title":"Discovery of kynurenines containing oligopeptides as potent opioid receptor agonists","volume":"10","author":"Sz\u0171cs","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuint.2020.104752_bib68","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.febslet.2006.08.015","article-title":"Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35","volume":"580","author":"Taniguchi","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2020.104752_bib69","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5\u2019-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2020.104752_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnbeh.2015.00157","article-title":"Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl\/6 mice","volume":"9","author":"Varga","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuint.2020.104752_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2020.104752_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature11896","article-title":"Molecular signatures of G-protein-coupled receptors","volume":"494","author":"Venkatakrishnan","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2020.104752_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigan\u00f2","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2020.104752_bib74","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2020.104752_bib75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0306-4522(00)00030-0","article-title":"Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo","volume":"97","author":"Wu","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2020.104752_bib76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuint.2013.12.005","article-title":"Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity","volume":"67","author":"Z\u00e1dor","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2020.104752_bib77","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/molecules24203709","article-title":"Kynurenines and the endocannabinoid system in schizophrenia: common points and potential interactions","volume":"24","author":"Z\u00e1dor","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2020.104752_bib78","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2174\/1871527314666141205164114","article-title":"Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors","volume":"13","author":"Z\u00e1dor","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuint.2020.104752_bib79","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1582-4934.2010.01237.x","article-title":"Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines","volume":"15","author":"Z\u00e1dori","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.neuint.2020.104752_bib80","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","article-title":"Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease","volume":"118","author":"Z\u00e1dori","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2020.104752_bib81","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1074\/jbc.M113.508382","article-title":"Crucial positively charged residues for ligand activation of the GPR35 receptor","volume":"289","author":"Zhao","year":"2014","journal-title":"J. Biol. Chem."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018620301431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018620301431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:50:36Z","timestamp":1759312236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018620301431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"alternative-id":["S0197018620301431"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2020.104752","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB1 receptors in rats","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2020.104752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104752"}}